BookimedはMRI検査価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。到着時にクリニックでMRI検査代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。MRI検査で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。MRI検査の旅路でお一人になることはありません。
Professor Yi Yao, MD, is Chief of the Epilepsy Center. He is an internationally recognized expert in functional neurology and neurosurgery. He specializes in complex epilepsy care for children and adults. He has over 35 years of experience.
Clinical expertise: brain mapping; drug-resistant epilepsy; emergency seizure care; advanced neurosurgical planning; microsurgery for tumors and vascular disease.
Professional leadership: Standing Council Member, China Association Against Epilepsy; Vice Chairman, Epilepsy Surgery Foundation; Committee Member, Pediatric Neurosurgery; Vice President, Fujian Epilepsy Association.
Dr. Li Ping, M.D., Ph.D., is Chief Physician and Professor in the Department of Hematology at Shanghai Tongji Hospital, Tongji University School of Medicine. She supervises doctoral and master's students and is an expert in hematologic malignancies.
She earned a Doctor of Medical Science from Nagoya University and completed postdoctoral research. She specializes in diagnosing and treating blood cancers. Her focus includes lymphoid malignancies—leukemias, lymphomas, and multiple myeloma. She treats patients with chemotherapy, hematopoietic stem cell transplantation, targeted therapy, and immunotherapy.
She is a pioneer in China in full-cycle CAR-T therapy for relapsed or refractory blood cancers. She leads and participates in national and international clinical trials. She serves on committees of professional societies, including the China Anti-Cancer Association. She also publishes and trains hematologists.
Professor ZHENG Wei Hong is Director of the Department of Neurology and the discipline leader. He previously served as Director of Neurology at Xiamen University Affiliated Zhongshan Hospital. He is a Professor at Xiamen University and a master's supervisor.
His clinical focus includes etiological investigation, prevention, and treatment of cerebral infarction and cerebral hemorrhage. He also diagnoses and treats complex neurological diseases, including epilepsy, neuroimmunological and neuromuscular disorders (myasthenia gravis, multiple sclerosis), and Parkinson's disease.
Appointments: He serves as a committee member of the Neuroimmunology Group (Chinese Medical Association Neurology Branch), the Immunology Branch (Chinese Stroke Association), Neurorestoration (Chinese Medical Doctor Association), and Cognitive Impairment (Chinese Geriatrics Society). He is on the Standing Committee of the Expert Committee of Stroke Screening and Prevention Engineering Base Hospitals (Ministry of Health). He is a member of the Neurology Expert Group, Fujian Provincial Medical Quality Control Center for Stroke and Epilepsy. He is Standing Director of the Fujian Anti‑Epilepsy Association. He is Deputy Group Leader of the Epilepsy and Electroencephalography Group (Fujian Medical Association Neurology Branch). He is Deputy Chairperson of the 1st Committee, Neurology Physicians Branch (Fujian Medical Doctor Association). He is a Standing Committee Member (5th–7th) of the Neurology Branch (Fujian Medical Association). He is Deputy Chairperson of the Neurology Professional Committee (Xiamen Medical Association).
Dr. LV Xiao Jun is the Executive Director of the Department of Medical Oncology. He is a national expert in psycho-oncology and has 30 years of clinical experience. He previously served at the First Affiliated Hospital of Xiamen University. He is a recognized expert in cancer treatment and lung cancer care in Fujian Province.
Clinical focus: comprehensive care for solid tumors, including lung, breast, and gastrointestinal cancers; palliative care in oncology; and screening and treatment for psychological distress.
Appointments: Standing Committee Member (third term), Psycho-Oncology Committee, Chinese Anti-Cancer Association; Standing Committee Member (third term), Lung Cancer Committee, Fujian Anti-Cancer Association.